scholarly journals Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes

2004 ◽  
Vol 199 (12) ◽  
pp. 1631-1640 ◽  
Author(s):  
Melissa W. Boulé ◽  
Courtney Broughton ◽  
Fabienne Mackay ◽  
Shizuo Akira ◽  
Ann Marshak-Rothstein ◽  
...  

Dendritic cell (DC) activation by nucleic acid–containing immunoglobulin (Ig)G complexes has been implicated in systemic lupus erythematosus (SLE) pathogenesis. However, the mechanisms responsible for activation and subsequent disease induction are not completely understood. Here we show that murine DCs are much more effectively activated by immune complexes that contain IgG bound to chromatin than by immune complexes that contain foreign protein. Activation by these chromatin immune complexes occurs by two distinct pathways. One pathway involves dual engagement of the Fc receptor FcγRIII and Toll-like receptor (TLR)9, whereas the other is TLR9 independent. Furthermore, there is a characteristic cytokine profile elicited by the chromatin immune complexes that distinguishes this response from that of conventional TLR ligands, notably the induction of BAFF and the lack of induction of interleukin 12. The data establish a critical role for self-antigen in DC activation and explain how the innate immune system might drive the adaptive immune response in SLE.

2006 ◽  
Vol 36 (7) ◽  
pp. 1674-1683 ◽  
Author(s):  
Laurence Guzylack-Piriou ◽  
Fabio Bergamin ◽  
Markus Gerber ◽  
Kenneth C. McCullough ◽  
Artur Summerfield

2007 ◽  
Vol 9 (14-15) ◽  
pp. 1606-1613 ◽  
Author(s):  
François Vanhoutte ◽  
Laetitia Breuilh ◽  
Josette Fontaine ◽  
Claudia S. Zouain ◽  
Thierry Mallevaey ◽  
...  

2010 ◽  
Vol 2 (2) ◽  
pp. 123-143 ◽  
Author(s):  
Marc A. Williams ◽  
Stephen Bauer ◽  
Wenju Lu ◽  
Jia Guo ◽  
Scott Walter ◽  
...  

2009 ◽  
Vol 183 (5) ◽  
pp. 3109-3117 ◽  
Author(s):  
Kei Yasuda ◽  
Christophe Richez ◽  
Melissa B. Uccellini ◽  
Rocco J. Richards ◽  
Ramon G. Bonegio ◽  
...  

2020 ◽  
Vol 48 (03) ◽  
pp. 597-613 ◽  
Author(s):  
Chun-Hsien Chen ◽  
Hsin-Chun Chen ◽  
Wen-Te Chang ◽  
Meng-Shiou Lee ◽  
Yi-Chen Liu ◽  
...  

Magnoliae Flos is a commonly used traditional medicinal material in Asia. It is used to treat sinusitis, nasal congestion, and hypersensitive skin. Because Magonlia Flos was described as an aromatic material in ancient Chinese texts, we hypothesized that its essential oil may be used to treat immune disorders. Dendritic cells (DCs), regarded as a major target of immunomodulators to control immune responses, play a critical role in the adaptive immune response. In this study, Magnoliae Flos essential oil (MFEO) decreased the production of the cytokines TNF-[Formula: see text], IL-6, and IL-12p70 in lipopolysaccharide (LPS)-stimulated DCs. It also suppressed the surface markers MHC II, CD80, and CD86 in LPS-stimulated DCs. Animal models demonstrated that the 2,4-Dinitro-1-fluorobenzene (DNFB) inducing a contact hypersensitivity response was inhibited following treatment with MFEO. In addition, MFEO inhibited the infiltration of T cells in the ears of DNFB-induced mice. To explore its bioactive compounds, the components of MFEO were analyzed using gas chromatography (GC) and GC-mass spectrometry. The results revealed that the major compounds in MFEO are camphor and 1,8-cineole. Additional DC bioassays confirmed that these compounds substantially suppressed cytokine production in LPS-induced DCs. Therefore, we demonstrated that MFEO exhibits an immunosuppressive effect both in vivo and in vitro, and camphor and 1,8-cineole may be the major components responsible for its immunosuppressive ability. The findings indicate that MFEO has the potential to be developed as a new immunosuppressant for excessive diseases.


2008 ◽  
Vol 22 (8) ◽  
pp. 1927-1934 ◽  
Author(s):  
Rebecca J. Dearman ◽  
Marie Cumberbatch ◽  
Craig Portsmouth ◽  
Gavin Maxwell ◽  
David A. Basketter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document